Citadel Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $290M | Buy |
4,782,000
+784,400
| +20% | +$45.7M | 0.05% | 318 |
|
|
2025
Q4 | $216M | Buy |
3,997,600
+163,300
| +4% | +$7.86M | 0.03% | 451 |
|
|
2025
Q3 | $173M | Buy |
3,834,300
+906,500
| +31% | +$42.3M | 0.03% | 541 |
|
|
2025
Q2 | $136M | Sell |
2,927,800
-640,400
| -18% | -$31.4M | 0.02% | 572 |
|
|
2025
Q1 | $218M | Sell |
3,568,200
-354,300
| -9% | -$20.7M | 0.04% | 345 |
|
|
2024
Q4 | $222M | Sell |
3,922,500
-2,996,000
| -43% | -$167M | 0.04% | 373 |
|
|
2024
Q3 | $358M | Sell |
6,918,500
-1,939,900
| -22% | -$91M | 0.07% | 201 |
|
|
2024
Q2 | $368M | Buy |
8,858,400
+3,882,700
| +78% | +$174M | 0.07% | 184 |
|
|
2024
Q1 | $270M | Buy |
4,975,700
+2,100,700
| +73% | +$107M | 0.05% | 276 |
|
|
2023
Q4 | $148M | Buy |
2,875,000
+122,400
| +4% | +$6.43M | 0.03% | 481 |
|
|
2023
Q3 | $160M | Sell |
2,752,600
-143,100
| -5% | -$8.77M | 0.03% | 396 |
|
|
2023
Q2 | $185M | Buy |
2,895,700
+113,500
| +4% | +$7.61M | 0.04% | 351 |
|
|
2023
Q1 | $193M | Sell |
2,782,200
-271,900
| -9% | -$19.2M | 0.04% | 335 |
|
|
2022
Q4 | $220M | Sell |
3,054,100
-733,000
| -19% | -$55.3M | 0.05% | 310 |
|
|
2022
Q3 | $269M | Buy |
3,787,100
+512,900
| +16% | +$37.2M | 0.06% | 210 |
|
|
2022
Q2 | $252M | Sell |
3,274,200
-58,900
| -2% | -$4.49M | 0.06% | 220 |
|
|
2022
Q1 | $243M | Sell |
3,333,100
-230,900
| -6% | -$15.5M | 0.05% | 274 |
|
|
2021
Q4 | $222M | Buy |
3,564,000
+939,700
| +36% | +$55.1M | 0.05% | 309 |
|
|
2021
Q3 | $155M | Buy |
2,624,300
+881,900
| +51% | +$58.1M | 0.03% | 444 |
|
|
2021
Q2 | $116M | Buy |
1,742,400
+607,900
| +54% | +$39.6M | 0.03% | 584 |
|
|
2021
Q1 | $71.6M | Sell |
1,134,500
-844,300
| -43% | -$52.5M | 0.02% | 777 |
|
|
2020
Q4 | $123M | Buy |
1,978,800
+1,105,900
| +127% | +$68M | 0.03% | 440 |
|
|
2020
Q3 | $52.6M | Sell |
872,900
-130,200
| -13% | -$7.84M | 0.01% | 827 |
|
|
2020
Q2 | $59M | Sell |
1,003,100
-1,300,900
| -56% | -$77.8M | 0.02% | 698 |
|
|
2020
Q1 | $128M | Buy |
2,304,000
+1,562,600
| +211% | +$95.5M | 0.06% | 249 |
|
|
2019
Q4 | $47.6M | Sell |
741,400
-1,109,200
| -60% | -$63.5M | 0.02% | 798 |
|
|
2019
Q3 | $93.8M | Sell |
1,850,600
-44,500
| -2% | -$2.09M | 0.04% | 430 |
|
|
2019
Q2 | $85.9M | Sell |
1,895,100
-1,295,400
| -41% | -$60.3M | 0.04% | 461 |
|
|
2019
Q1 | $152M | Buy |
3,190,500
+1,784,700
| +127% | +$88.9M | 0.08% | 216 |
|
|
2018
Q4 | $73.1M | Sell |
1,405,800
-264,800
| -16% | -$14.2M | 0.04% | 451 |
|
|
2018
Q3 | $104M | Buy |
1,670,600
+269,900
| +19% | +$16M | 0.05% | 401 |
|
|
2018
Q2 | $77.5M | Buy |
1,400,700
+181,800
| +15% | +$9.82M | 0.04% | 472 |
|
|
2018
Q1 | $77.1M | Buy |
1,218,900
+482,900
| +66% | +$31.1M | 0.04% | 410 |
|
|
2017
Q4 | $45.1M | Sell |
736,000
-165,300
| -18% | -$10.3M | 0.03% | 667 |
|
|
2017
Q3 | $57.4M | Sell |
901,300
-152,400
| -14% | -$8.9M | 0.04% | 479 |
|
|
2017
Q2 | $58.7M | Sell |
1,053,700
-89,300
| -8% | -$4.86M | 0.05% | 425 |
|
|
2017
Q1 | $62.2M | Buy |
1,143,000
+272,200
| +31% | +$14.9M | 0.06% | 348 |
|
|
2016
Q4 | $50.9M | Sell |
870,800
-638,400
| -42% | -$34.9M | 0.05% | 380 |
|
|
2016
Q3 | $81.4M | Buy |
1,509,200
+919,900
| +156% | +$59.1M | 0.08% | 215 |
|
|
2016
Q2 | $43.3M | Buy |
589,300
+60,100
| +11% | +$4.25M | 0.05% | 395 |
|
|
2016
Q1 | $33.8M | Buy |
529,200
+225,600
| +74% | +$14.2M | 0.04% | 454 |
|
|
2015
Q4 | $20.9M | Sell |
303,600
-98,200
| -24% | -$6.49M | 0.02% | 819 |
|
|
2015
Q3 | $23.8M | Buy |
401,800
+195,000
| +94% | +$12.4M | 0.02% | 794 |
|
|
2015
Q2 | $13.8M | Buy |
206,800
+16,000
| +8% | +$1.05M | 0.01% | 1255 |
|
|
2015
Q1 | $12.3M | Buy |
190,800
+59,200
| +45% | +$3.71M | 0.01% | 1287 |
|
|
2014
Q4 | $7.77M | Sell |
131,600
-62,600
| -32% | -$3.53M | 0.01% | 1598 |
|
|
2014
Q3 | $9.94M | Buy |
194,200
+99,400
| +105% | +$4.97M | 0.01% | 1366 |
|
|
2014
Q2 | $4.6M | Sell |
94,800
-79,900
| -46% | -$3.94M | 0.01% | 1901 |
|
|
2014
Q1 | $9.08M | Sell |
174,700
-160,400
| -48% | -$8.54M | 0.01% | 1335 |
|
|
2013
Q4 | $17.8M | Sell |
335,100
-365,000
| -52% | -$18.6M | 0.02% | 868 |
|
|
2013
Q3 | $32.4M | Buy |
700,100
+312,200
| +80% | +$13.7M | 0.05% | 494 |
|
|
2013
Q2 | $17.3M | Buy |
+387,900
| New | +$16.8M | 0.03% | 735 |
|
Other funds holding BMY
VCM
VPM
Citadel Advisors's BMY Position: Q1 2026 in Review
Citadel Advisors increased its Bristol-Myers Squibb (BMY) stake by 46% in Q1 2026, buying an estimated $27.5M and bringing the position to 1,494,234 shares worth $90.6M. The position accounts for 0.01% of the portfolio, ranked #884.
Citadel Advisors first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $456M in Q2 2024. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Citadel Advisors held 1,494,234 shares of Bristol-Myers Squibb worth $90.6M as of Q1 2026.
- Citadel Advisors bought 471,773 Bristol-Myers Squibb shares in Q1 2026, an estimated $27.5M.
- Bristol-Myers Squibb made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #884 holding.
- Citadel Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Citadel Advisors's Bristol-Myers Squibb position peaked at $456M in Q2 2024.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.